Early Discoveries, With More to Come So far, GLP-1s, first approved 20 years ago for type 2 diabetes and later obesity, have shown potential in treating a surprisingly wide range of conditions, such as heart disease, Parkinsons, Alzheimers, sleep apnea, and liver disease
What Research Says about GLP-1 A 2015 study in the Annals of Internal Medicine found: Increasing fiber intake alone may be sufficient for weight loss. Several publications and Research in JAMA discusses how GLP-1 receptor agonists increase satiety and slow digestion
The FDA-approved GLP-1 medications come in injectable pens with precise dosing, whereas compounded GLP-1 drugs typically come in a vial with a syringe that can offer more flexibility for microdosing, but also opens up the chance for taking too much or too little medication
STEP 5: the two-year study Duration matters for understanding the full timeline
At 20mg/mL concentration: 2.5mg equals 12.5 units
They need affordable access to GLP-1 prescriptions for weight loss without insurance barriers